CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+12.33%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$15.6B
AUM Growth
+$1.15B
(+7.9%)
Cap. Flow
-$216M
Cap. Flow
% of AUM
-1.38%
Top 10 Holdings %
Top 10 Hldgs %
27.58%
Holding
755
New
44
Increased
354
Reduced
220
Closed
56
Top Buys
| 1 |
NVIDIA
NVDA
|
+$80.1M |
| 2 |
Salesforce
CRM
|
+$55.1M |
| 3 |
Micron Technology
MU
|
+$53.8M |
| 4 |
Apple
AAPL
|
+$50M |
| 5 |
Applied Materials
AMAT
|
+$48.3M |
Top Sells
| 1 |
Merck
MRK
|
+$73.5M |
| 2 |
ANSS
Ansys
ANSS
|
+$53.4M |
| 3 |
Adobe
ADBE
|
+$51.7M |
| 4 |
TJX Companies
TJX
|
+$41.4M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$39.6M |
Sector Composition
| 1 | Technology | 31.73% |
| 2 | Healthcare | 28.37% |
| 3 | Financials | 8.73% |
| 4 | Consumer Discretionary | 8.29% |
| 5 | Industrials | 6.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Akamai
AKAM
$11.2B
| $6.19M | 0.04% |
56,875
+709
| +1% | +$77.1K |
|
302
Sempra
SRE
$52.4B
| $6.12M | 0.04% |
85,163
-225,025
| -73% | -$16.2M |
|
303
Autoliv
ALV
$9.66B
| $6.08M | 0.04% |
50,478
+7,872
| +18% | +$948K |
|
304
Evolent Health
EVH
$1.16B
| $6.07M | 0.04% |
185,228
+6,565
| +4% | +$215K |
|
305
Akero Therapeutics
AKRO
$3.57B
| $6.06M | 0.04% |
240,000
+56,000
| +30% | +$1.41M |
|
306
Snowflake
SNOW
$76.4B
| $6.03M | 0.04% |
37,319
-37,860
| -50% | -$6.12M |
|
307
Edgewise Therapeutics
EWTX
$1.55B
| $6M | 0.04% |
329,000
+21,000
| +7% | +$383K |
|
308
Montrose Environmental
MEG
$1.01B
| $6M | 0.04% |
153,099
+3,449
| +2% | +$135K |
|
309
Axsome Therapeutics
AXSM
$6.27B
| $5.99M | 0.04% |
75,084
-10,000
| -12% | -$798K |
|
310
Apogee Therapeutics
APGE
$2.29B
| $5.98M | 0.04% |
+90,000
| New | +$5.98M |
|
311
Treace Medical Concepts
TMCI
$467M
| $5.94M | 0.04% |
454,945
+104,945
| +30% | +$1.37M |
|
312
Robert Half
RHI
$3.65B
| $5.93M | 0.04% |
16,274
+3,466
| +27% | +$1.26M |
|
313
Hubbell
HUBB
$23.2B
| $5.91M | 0.04% |
14,247
+7,803
| +121% | +$3.24M |
|
314
NeoGenomics
NEO
$1.02B
| $5.9M | 0.04% |
375,017
+170,010
| +83% | +$2.67M |
|
315
Caribou Biosciences
CRBU
$171M
| $5.89M | 0.04% |
1,145,063
+285,039
| +33% | +$1.47M |
|
316
Howard Hughes
HHH
$4.64B
| $5.88M | 0.04% |
84,946
+41,757
| +97% | +$2.89M |
|
317
US Bancorp
USB
$76.8B
| $5.81M | 0.04% |
129,894
-255,010
| -66% | -$11.4M |
|
318
Structure Therapeutics
GPCR
$1.22B
| $5.79M | 0.04% |
135,000
-75,000
| -36% | -$3.21M |
|
319
FedEx
FDX
$53.3B
| $5.67M | 0.04% |
19,576
+1,578
| +9% | +$457K |
|
320
Marathon Petroleum
MPC
$55.7B
| $5.62M | 0.04% |
27,888
-28
| -0.1% | -$5.64K |
|
321
Omnicom Group
OMC
$15.1B
| $5.61M | 0.04% |
57,931
+43,239
| +294% | +$4.18M |
|
322
News Corp Class A
NWSA
$16.6B
| – | – |
0
| – | – |
|
323
Biohaven
BHVN
$1.53B
| $5.47M | 0.04% |
+100,000
| New | +$5.47M |
|
324
Expeditors International
EXPD
$16.4B
| $5.43M | 0.03% |
44,650
+17,727
| +66% | +$2.16M |
|
325
Encompass Health
EHC
$12.6B
| $5.37M | 0.03% |
64,984
+2,304
| +4% | +$190K |
|